Cosmetics left out of Canadian organic regs
This article was originally published in The Rose Sheet
Executive Summary
Some sectors of the industry, including personal care and cosmetics, "have expressed concern that a number of organic products which are regulated at the provincial level are not included in the scope of application" of the proposed Organic Products Regulations published Feb. 14 in the Canada Gazette (Part I). The regs apply to food and drink intended for human consumption as well as food intended to feed livestock, including agricultural crops used for those purposes, and are to be enforced by the Canadian Food Inspection Agency (CFIA). According to a regulatory impact analysis statement, further consultation is needed to determine whether personal-care products and other outlying commodities "should fall under the proposed regulations or whether their organic status should be governed by another government department, agency or body." The organic regulations are slated to go into effect June 30 following a public comment period. The Organic Trade Association in Canada states: "When these regulations come into effect this summer, consumers will have a clear idea of what organic is, and will know the [CFIA] is monitoring and enforcing organic claims in the marketplace.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.